Necrostatin-1 and necroptosis inhibition: Pathophysiology and therapeutic implications

L Cao, W Mu - Pharmacological research, 2021 - Elsevier
Abstract Necrostatin-1 (Nec-1) is a RIP1-targeted inhibitor of necroptosis, a form of
programmed cell death discovered and investigated in recent years. There are already …
被引用次数：152 相关文章

Necrostatin-1 and necroptosis inhibition: Pathophysiology and therapeutic implications

L Cao, W Mu - Pharmacological research, 2021 - pubmed.ncbi.nlm.nih.gov
Necrostatin-1 (Nec-1) is a RIP1-targeted inhibitor of necroptosis, a form of programmed cell
death discovered and investigated in recent years. There are already many studies …
[HTML] nih.gov

[HTML][HTML] Necrostatin-1 and necroptosis inhibition: Pathophysiology and therapeutic implications

L Cao, W Mu - Pharmacological Research, 2021 - ncbi.nlm.nih.gov
ABSTRACT Necrostatin-1 (Nec-1) is a RIP1-targeted inhibitor of necroptosis, a form of
programmed cell death discovered and investigated in recent years. There are already …

[引用][C] Necrostatin-1 and necroptosis inhibition: Pathophysiology and therapeutic implications

L Cao, W Mu - Pharmacological Research, 2021 - cir.nii.ac.jp
Necrostatin-1 and necroptosis inhibition: Pathophysiology and therapeutic implications | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

Necrostatin-1 and necroptosis inhibition: Pathophysiology and therapeutic implications.

L Cao, W Mu - Pharmacological Research, 2020 - europepmc.org
ABSTRACT Necrostatin-1 (Nec-1) is a RIP1-targeted inhibitor of necroptosis, a form of
programmed cell death discovered and investigated in recent years. There are already …